Final Exam Module 7 & 8 Flashcards
(129 cards)
What condition?
Genetic hemoglobin disorder; formation of abnormal hemoglobin chains. Autosomal recessive pattern of inheritance.
Patho: Clumps block flow (vaso-occlusive event) causing tissue to become hypoxic. Results in inadequate perfusion and ischemia
Sickle cell crisis
Conditions that may cause sickling
hypoxia, dehydration, infection, venous stasis, pregnancy, alcohol consumption, nicotine use, high altitudes, acidosis, strenuous exercise, emotional stress, anesthesia, low/high environmental or body temperature
Important to understand the s/sx of sickle cell crisis and to prioritize which one(s) are of most concern!
Pain and reduced perfusion
**Pain is the most common SCD crisis symptom
Cardiovascular changes
Murmurs, JVD, peripheral pulses, capillary refill. Signs of decreased perfusion?
Respiratory changes
Risk for recurrent pneumonia, pulmonary HTN; assess for shortness of breath
Skin changes
Pallor, cyanosis (lips, nail beds), etc.
Lower extremity ulcers > may become infected and necrotic
Abdominal changes
Damage to spleen and/or liver > enlargement; jaundice
Kidney and urinary changes
Decreased urine output? Risk for chronic kidney disease
Musculoskeletal changes
Joint pain; assess range of motion and pain with movement
Central nervous system changes
Seizures, stroke-like symptoms
Potential complications r/t Sickle cell crisis
-Infection
-Chronic Kidney Disease
-Necrotic Ulcers on LE
-Acute Chest Syndrome (common reason for hospitalization & most common cause of death)
-Respiratory infection or embolism
It is important to know the treatment options for managing pain in a sickle cell patient. Which pain management intervention is the better option?
Remember- SCD patients face a lot of healthcare stigma
-IV Analgesia – typically Morphine or Dilaudid for 48 hours via PCA
-Oral opiates or NSAIDS for moderate pain
-Integrative therapies: keeping room temp. warm, distraction and relaxation, aromatherapy, warm soaks and compresses
-Hydroxyurea: stimulates fetal hemoglobin production (long term risk for leukemia)
-Endari: delays and decreases complications of SCD. Composed of amino acid glutamine (lowers oxidative stress and decreases sickling rates)
-Crizanlizumab: monoclonal antibody that inhibits selection. Prevents adhesion and vaso-occlusive crises.
Why should we nebulize O2 when providing oxygen to SCD patients?
prevent dehydration
What antibiotic is used to prevent infection in SCD patients?
This antibiotic decreases the number of pneumonia and streptococcal infections.
Penicillin BID
SCD- Things to remember regarding transfusions
-Increased HbA levels and dilutes HbS levels
-Risk for iron overload with repeat transfusion
-Assess for transfusion reactions
What condition?
Destructive reduction of circulating platelets after normal platelet production
Thrombocytopenia
What are the three types of thrombocytopenia?
Autoimmune thrombocytopenia purpura (ATP)
Thrombotic thrombocytopenia purpura (TTP)
Heparin-induced thrombocytopenia (HIT)
What type of thrombocytopenia?
Antibodies are produced against platelets, then platelets are destroyed by macrophages in the spleen. Platelet production still occurs but may not be able to keep up with the number of platelets being destroyed.
Clotting impaired with decreased number of platelets
Autoimmune thrombocytopenia purpura (ATP)
Important to understand the medications used to treat ATP and why they are being used.
Treatment is initiated with platelet counts less than 50,000, active bleeding, or high risk for bleeding.
Main MOA is immunosuppression
-Corticosteroids
-Azathioprine (DMARD)
-Eltrombopag
-Rituximab
-Romiplostim
ATP complications include:
hemorrhage and intracranial bleeding-induced stroke
Surgical management for ATP?
splenectomy for pts who do not respond to drug therapy
Spleen is site of excessive platelet destruction
What type of thrombocytopenia?
Abnormality of platelet clumping during trauma or surgery. Caused by autoimmune reaction in small blood vessels that starts platelet clotting and aggregation at the endothelial cells. Clots and platelet plugs formed where not needed, and failure to clot at site of trauma. Tissue becomes ischemic leading to kidney failure, MI, and stroke.
Thrombotic thrombocytopenia purpura (TTP)
Drug therapy used for TTP
Antiplatelets (aspirin, alprostadil, plicamycin) and immunosuppressive therapy
How do we manage TTP?
Prevent platelet clumping and stopping the autoimmune process- plasma removal and FFP.
If TTP is left untreated it is fatal within 3 months.
What type of thrombocytopenia?
Potentially devastating immune-mediated adverse drug reaction caused by the emergence of antibodies that activate platelets in the presence of heparin. Can occur in patients receiving any type of heparin, although it is more common after exposure to unfractionated heparin.
Heparin-induced thrombocytopenia (HIT)
Higher incidence of HIT among patients with risk factors of:
-Duration of heparin use longer than one week
-Exposure to unfractionated heparin
-Postsurgical thromboprophylaxis
-Being female
S/sx of HIT
venous thromboembolism (VTE) such as DVT and PE
What is the hallmark sign of HIT? What labs are important to monitor?
Thrombocytopenia after heparin exposure.
Important to monitor pt’s platelet levels when they are on heparin therapy. A drastic drop in platelets is a RED FLAG and a can’t miss!
Drug management for HIT is focused on direct thrombin inhibitor. What meds are used?
argatroban (Acova) and lepirudin (Refludan)
HIT cues to watch out for?
large bruises, mucosal bleeding, petechial rash, and anemia
What type of transfusion?
Replaces cells lost form trauma or surgery. Donor and recipient must be assessed for compatibility.
RBC transfusion